QTNT - Quotient Limited
| Previous Close | 4.49 |
| Open | 4.44 |
| Bid | 4.05 x 300 |
| Ask | 10.00 x 300 |
| Day's Range | 4.37 - 4.48 |
| 52 Week Range | 2.78 - 7.74 |
| Volume | 90,167 |
| Avg. Volume | 427,215 |
| Market Cap | 201.044M |
| Beta | -0.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.24 |
| Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.50 |
- GlobeNewswire•26 days ago
Quotient Limited Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction
Verification & Validation“ head-to-head” data exceeds target concordance for blood grouping Overall concordance for antigen typing– 99.8%, demonstrating robustness of the MosaiQ platform Completion of ...
- GlobeNewswire•26 days ago
Quotient Limited Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer
JERSEY, Channel Islands, March 26, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced the retirement of Paul Cowan as its Chairman and Chief Executive Officer. Franz Walt, ...
- Simply Wall St.•last month
Quotient Limited (NASDAQ:QTNT): Does The -11.14% Earnings Drop Reflect A Longer Term Trend?
Understanding how Quotient Limited (NASDAQ:QTNT) is performing as a company requires looking at more than just a years’ earnings. Today I will run you through a basic sense check toRead More...
- GlobeNewswire•2 months ago
Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference
JERSEY, Channel Islands, March 01, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at ...
- GlobeNewswire•2 months ago
Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility
JERSEY, Channel Islands, Feb. 20, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the sale and leaseback of its recently completed ...
- GlobeNewswire•2 months ago
Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director
JERSEY, Channel Islands, Feb. 20, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective February 19, 2018. Walt ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of QTNT earnings conference call or presentation 6-Feb-18 1:30pm GMT
Q3 2018 Quotient Ltd Earnings Call
- Associated Press•2 months ago
Quotient reports 3Q loss
The Eysins, Jersey-based company said it had a loss of 47 cents per share. The blood test developer posted revenue of $5.9 million in the period. Quotient expects full-year revenue in the range of $24.1 ...
- GlobeNewswire•2 months ago
Quotient Limited Updates on Status of MosaiQ Performance and Provides Third Quarter Fiscal 2018 Financial Results
Manufacturing process change implemented with improved assay performance Verification and Validation studies for blood grouping to resume MosaiQ SDS Microarray preparing to enter into formal V&V studies ...
- GlobeNewswire•3 months ago
Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference
JERSEY, Channel Islands, Jan. 31, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the ...
- GlobeNewswire•3 months ago
Quotient Limited to Report Fiscal Third Quarter 2018 Financial Results and Host Conference Call
JERSEY, Channel Islands, Jan. 23, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2017, will be released ...
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of QTNT earnings conference call or presentation 23-May-17 12:00pm GMT
Q4 2017 Quotient Ltd Earnings Call
- Simply Wall St.•5 months ago
Is Quotient Limited (QTNT) Overpaying Its CEO?
Leading Quotient Limited (NASDAQ:QTNT) as the CEO, D. J. Paul Cowan took the company to a valuation of USD$196.82M. Understanding how CEOs are incentivised to run and grow their companyRead More...
- Capital Cube•5 months ago
ETFs with exposure to Quotient Ltd. : November 6, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Quotient Ltd. Here are 5 ETFs with the largest exposure to QTNT-US. Comparing the performance and risk of Quotient Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•6 months agoQuotient Ltd. :QTNT-US: Earnings Analysis: Q2, 2018 By the Numbers : November 3, 2017
Categories: Yahoo FinanceGet free summary analysis Quotient Ltd. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Quotient Ltd. – Baxter International Inc. (BAX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 5.91 million, Net Earnings of USD -21.69 million. Gross ... Read more (Read more...)
- Associated Press•6 months ago
Quotient reports 2Q loss
The Penicuik, Britain-based company said it had a loss of 58 cents per share. The blood test developer posted revenue of $5.9 million in the period. Quotient expects full-year revenue in the range of $25 ...
- Simply Wall St.•6 months ago
Are Quotient Limited’s (QTNT) Interest Costs Too High?
Investors are always looking for growth in small-cap stocks like Quotient Limited (NASDAQ:QTNT), with a market cap of USD $174.78M. However, an important fact which most ignore is: how financiallyRead More...
